Paper Details

  1. Home
  2. Paper Details

TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD): Design and implementation of randomized clinical trial.

Author: CollinsJoseph F, CrossRaymond K, JambaulikarGuruprasad, KatzJonathan, LangenbergPatricia, QuinnCharlene C, RegueiroMiguel, SchwartzDavid A, TracyJ Kathleen

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

Inflammatory bowel diseases (IBD), like ulcerative colitis and Crohn's disease, are chronic conditions with alternating periods of worsening symptoms and symptom-free periods. These symptoms severely impact quality of life and lead to increased healthcare use. Although effective treatments exist, outcomes are often poor due to factors like non-adherence to treatment, medication intolerance, inconsistent monitoring, insufficient patient understanding, and limited access to care.
Paper Details　
Original Abstract of the Article :
Inflammatory bowel diseases (IBD), comprised of ulcerative colitis and Crohn's disease, are chronic disorders characterized by worsening of symptoms followed by symptom-free periods. Symptoms have a profound negative impact on quality of life and are associated with increased health care utilization...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.cct.2015.03.006

データ提供：米国国立医学図書館（NLM）

TELEmedicine for Inflammatory Bowel Disease (TELE-IBD): A New Frontier in Healthcare Delivery

[Inflammatory bowel diseases (IBD)] are chronic conditions that cause [inflammation] of the digestive tract. Managing [IBD] requires [ongoing monitoring] and [patient education] to ensure optimal treatment outcomes. This study explores the potential of [TELEmedicine] as a tool for improving [IBD] care.

Bridging the Gap: TELEmedicine's Role in IBD Management

The study highlights the challenges faced by [IBD patients], including [nonadherence to medication, medication intolerance, inconsistent monitoring, poor patient knowledge, and limited access to care]. The researchers propose a [randomized clinical trial] to evaluate the effectiveness of [TELEmedicine] in addressing these challenges. They believe that [TELEmedicine] can provide [remote monitoring, virtual consultations, and personalized education] to patients, potentially improving [patient engagement, treatment adherence, and overall outcomes].

Transforming IBD Care: A New Era of Healthcare Delivery

This study represents a significant step towards [transforming IBD care], utilizing technology to bridge geographical and logistical barriers. It's like finding a new caravan route through a vast desert, making it easier to reach distant oases and access essential resources. This research holds great promise for improving [IBD care] and potentially impacting the lives of countless patients.

Dr. Camel's Conclusion

This research explores the potential of [TELEmedicine] to revolutionize [IBD] care, offering patients greater accessibility and personalized support. It's like discovering a new oasis in a vast desert, providing a much-needed source of relief and hope for those navigating the challenges of chronic illness.
Date :
  1. Date Completed 2016-02-25
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

25812483

DOI: Digital Object Identifier

10.1016/j.cct.2015.03.006

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.